Christopher A. Seeger

Partner
Get in touch

A founding partner of Seeger Weiss, Chris is widely recognized as a highly innovative and accomplished plaintiff attorney. Since founding the firm in 1999, he has led some of the most complex, groundbreaking and high-profile litigations in the U.S., at both the state and federal level.

Chiefly known for multidistrict mass torts and class actions involving drug injury, toxic injury and personal injury, Chris’s versatile practice also includes product liability; property damage; consumer, insurance and securities fraud; antitrust; and third-party payer litigation.

CHRIS A. SEEGER

A founding partner of Seeger Weiss, Chris is widely recognized as a highly innovative and accomplished plaintiff attorney. Since founding the firm in 1999, he has led some of the most complex, groundbreaking and high-profile litigations in the U.S., at both the state and federal level.

Chiefly known for multidistrict mass torts and class actions involving drug injury, toxic injury and personal injury, Chris’s versatile practice also includes product liability; property damage; consumer, insurance and securities fraud; antitrust; and third-party payer litigation.

Selected by the courts to serve as Lead Counsel, Co-Lead Counsel, Liaison Counsel, or member of the Plaintiffs’ Executive and/or Steering Committee in dozens of proceedings, Chris’s unique experience makes him a knowledgeable and capable litigator, highly regarded among his colleagues. In both capacities, he brings all his skill to bear in service of his clients’ interests.

Chris is regularly quoted in the press as the plaintiff counsel in nationally and internationally prominent cases, including the New York Times, Wall Street Journal, Chicago Tribune, Los Angeles Times, Bloomberg, CBS, CNBC, USA Today, Daily News, ESPN, and HBO Sports.

Chris started his career as a corporate defense lawyer representing Big Business interests. Struck by the imbalance of power between corporations and the individuals victimized by them, he left to become a plaintiff attorney. Now, whether a class action involving thousands of people against a multinational conglomerate or an individual case protecting one client’s rights, he fights with the same passion and conviction. As the son of a union carpenter who worked his way through school, a former amateur boxer and a current Brazilian Jiu Jitsu black belt, Chris believes in standing up for the little guy—and willing to go to the mat for him.

Bar Admissions

  • New York
  • New Jersey
  • U.S. District Courts of the Eastern District of New York
  • Southern District of New York
  • District of New Jersey
  • District of Colorado

MEMBERSHIPS & ASSOCIATIONS

Memberships & Associations

  • American Bar Association
  • The Association of the Bar of the City of New York
  • New Jersey State Bar Association
  • New York State Trial Lawyers Association
  • International Society of Barristers
  • American Bar Foundation
  • American Association for Justice
  • Trial Lawyers for Public Justice
  • Elected Member, American Law Institute
  • Leadership Council, Bolsch Judicial Institute at Duke Law
  • Advisory Board, RAND Center for Catastrophic Risk Management and Compensation
  • Advisory Board, Center on Civil Justice at New York University School of Law
  • Advisory Council, Duke Law Center for Judicial Studies
  • Dean’s Advisory Counsel, Benjamin N. Cardozo School of Law
  • Board of Trustees, Hunter College Foundation
  • Pre-Law Advisory Board, Hunter College
  • Co-General Counsel, Badge of Honor Memorial Foundation, 2008 – present

Pro Bono:

  • Human Rights First
  • Hunter College
  • Benjamin N. Cardozo School of Law
  • New York State Trial Lawyers Association (NYSTLA)
  • Badge of Honor Memorial Foundation

SELECTED REPRESENTATION

  • In re Volkswagen “Clean Diesel” Marketing, Sales Practices and Products Liability Litigation, MDL No. 2672 (N.D. Ca.). Appointed to Plaintiffs’ Steering Committee by the Honorable Charles R. Breyer, representing individuals affected by the Volkswagen diesel emissions controversy. Served on the Settlement Committee and was one of the lead negotiators of a $21 billion settlement which includes a massive buyback program for consumers and billions of dollars for environmental remediation.
  • In re National Football League Players’ Concussion Injury Litig., MDL No. 2323 (E.D. Pa.). Appointed Co-Lead Class Counsel by the Honorable Anita Brody, serving as chief negotiator on behalf of plaintiffs in the highly visible and contentious multidistrict litigation against the National Football League. There, Chris faced significant legal and procedural challenges, including those associated with federal preemption, causation and sub-classing. Ultimately, he was able to surmount these hurdles and lead settlement negotiations under the auspices of a mediator, and in coordination with subclass counsel. The results achieved there—an uncapped settlement fund valued at approximately $1 billion and a medical testing program—were overwhelmingly supported by the class and received unprecedented media attention. This settlement was approved by the Third Circuit Court of Appeals and certification of appeal was recently denied by the United States Supreme Court.
  • In re Syngenta AG MIR 162 Corn Litigation, MDL No. 14-md-2591 (D. Kan.). Appointed to the Plaintiffs’ Settlement Negotiating Committee by the Honorable John W. Lungstrum, serving as one of the principal negotiators in representing nationwide corn producers harmed as a result of Swiss agrochemical giant Syngenta AG’s premature commercialization of genetically modified strains of corn known as Agrisure Viptera and Duracade. A federal jury verdict of $217.7 million in compensatory damages in a Kansas class-wide trial led to the announcement in December 2018 of a nationwide settlement of $1.5 billion.
  • In re Testosterone Replacement Therapy Prods. Liab. Litig., MDL No. 2545 (N.D. Ill.) Appointed Co-Lead Counsel by the Honorable Matthew Kennelly, representing the interests of individuals who were injured by testosterone medications.
  • In re National Prescription Opiate Litig., MDL No. 2804 (N.D. Ohio). Appointed to the Executive and Settlement Committees by the Hon. Dan A. Polster, leading numerous lawsuits, many filed by local governments, against pharmaceutical manufacturers and distributers over the alleged improper and misleading marketing and widespread diversion of prescription painkillers into states, counties and cities across the nation, leading to the current opioid addiction crisis.
  • In re Intel Corp. CPU Marketing, Sales Practices and Prods. Liab. Litig., MDL No. 2828 (JPML). Appointed Interim Co-Lead Counsel in the nationwide lawsuit against Intel Corp., prosecuting fraud, product defect, and related claims on behalf of consumers who purchased computers and other devices containing flawed computer chips.
  • In re Fresenius Granuflo/Naturalyte Dialysate Prods. Liab. Litig., MDL No. 2428 (D. Mass.). Appointed to the Plaintiffs’ Executive Committee by the Honorable Douglas P. Woodlock.
  • In re Zyprexa Prods. Liab. Litig., MDL No. 1596 (E.D.N.Y.). Appointed as Liaison Counsel by the Honorable Jack B. Weinstein, serving as one of the chief negotiators in connection with a national $700 million settlement with Eli Lilly for over 8,000 claims that Zyprexa caused diabetes-related injuries. This was followed by a $500 million second-round settlement. Chris was the first to conceive of and use a global lien resolution administrator in the class or mass action context to resolve government and/or third party liens, resulting in significant savings and quicker payments to class members.
  • In re Depuy Orthopaedics, Inc. ASR Hip Implant Prods. Multidistrict Litig., MDL No. 2197 (N.D. Ohio). Appointed to the Plaintiffs’ Executive Committee by the Honorable David A. Katz, involved in negotiating an almost $3 billion settlement.
  • In re Yasmin and YAZ Marketing, Sales Practices and Prods. Liab. Litig., MDL No. 2100 (S.D. Ill.). Appointed to the Plaintiffs’ Steering Committee by the Honorable David R. Herndon. Was the first to settle own clients’ cases, which ultimately led to the creation of nationwide settlement program exceeding $2 billion.
  • In re Vioxx Prods. Liab. Litig., MDL No. 1657 (E.D. La.). Unanimously selected by the plaintiffs’ lawyers as Co-Lead Counsel and appointed by the Honorable Eldon E. Fallo. Developed the overall litigation strategy for the approximately 27,000 separate cases against Merck & Co., securing a settlement for $4.85 billion following five years of intense litigation, but mere months after obtaining a jury verdict of $47.5 million in a client’s bellwether trial (Humeston v. Merck & Co., Inc., case no. ATL-L-2272-03, N.J. Super. Ct. Atlantic County). Conceived and used a global lien resolution administrator, resulting in significant savings and quicker payments to class members.
  • In re Chinese-Manufactured Drywall Prods. Liab. Litig., MDL No. 2047 (E.D. La.). Appointed as Chair of the Plaintiffs’ Trial Committee by the Honorable Eldon E. Fallon in, serving as lead trial counsel in obtaining successful verdicts in a succession of bellwether liability and damages trials on behalf close to 5,000 property owners who used the allegedly toxic drywall, many in rebuilding homes destroyed by Hurricane Katrina. These verdicts served as the precursor to a national settlement valued at approximately $1 billion with worldwide drywall distributor Knauf Plasterboard Tianjin (KPT) in 2011.
  • In re Invokana (Canagliflozin) Prods. Liab. Litig., MDL No. 2750 (D.N.J.). Appointed by the Honorable Brian R. Martinotti as Co-Lead Counsel of the Plaintiffs’ Steering Committee on January 24, 2017, representing plaintiffs against Johnson & Johnson Co. and Janssen Pharmaceuticals, Inc., claiming injuries including diabetic ketoacidosis, acute kidney failure and amputations as a result of taking the drug Invokana. Case pending.
  • In re Actos (Pioglitazone) Prods. Liab. Litig., Case no. 6:11-md-2299 (W.D. La.). Appointed by the Honorable Rebecca F. Doherty to the Plaintiffs’ Steering Committee of the consolidated MDL, obtaining a jury verdict of $9 billion in punitive damages, the seventh-largest verdict in US history (later reduced to $36.8 million), against Takeda Pharmaceutical Co., Asia’s largest drug maker, and marketing partner Eli Lilly & Co., on behalf of plaintiffs who developed bladder cancer resulting from their Actos diabetes drug.
  • In re Phenylpropanolamine (PPA) Prods. Liab. Litig., MDL No. 1407 (W.D. Wash.). Served as principal negotiator and Co-Lead Counsel in the nationwide settlement of all PPA (phenylpropanolamine)-related injuries resulting from the ingestion of weight loss product Dexatrim. Was involved in the litigation against numerous other manufacturers of pharmaceuticals containing PPA, serving on the MDL Plaintiffs’ Steering Committee in the Western District of Washington and as Liaison Counsel in the New York state court litigation. Plaintiffs were awarded over $40 million.

*Prior results do not guarantee or predict a similar outcome in any future matter.

Awards

*No aspect of the advertisements below has been approved by the Supreme Court of New Jersey. Prior results do not guarantee a similar outcome. A description of the standard or methodology for each honor, award, or accolade listed below can be found here.

  • Award

    Chambers USA, Tier 1 Nationwide in Product Liability: Plaintiffs, 2013, 2017–2019, 2020-2021

    Chris has been listed by Chamber and Partners as ‘Top Ranked’ in the category Product Liability: Plaintiffs 2013, 2017-2019, 2020-2021 Chambers USA, Tier 1 Nationwide. The Chambers selection methodology can be found here.

  • Award

    Nation’s Top One Percent, National Association of Distinguished Counsel, 2015-2021

    Chris was recognized as Nation’s Top One Percent by the National Association of Distinguished Counsel. The NADC selection methodology can be found here.

  • Award

    Lawdragon Legends – 50 lawyers who made the Lawdragon 500 list 10 consecutive years, 2015

    Lawdragon 500 Leading Lawyers in America, 2007-2021

    Chris has been selected for inclusion on Lawdragon’s 2007-2021 list of 500 Leading Lawyers. This guide, first published in 2007 by Lawdragon Inc., presents Lawdragon’s opinion of “the best of the U.S. plaintiff bar who specialize in representing individual investors and shareholders, as well as businesses and other organizations harmed by corporate misconduct or other failures.” Lawdragon’s selection methodology is based on a combination of objective criteria including research of top verdicts and settlements, peer recognition, and interviews with lawyers throughout the country. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

  • Award

    Lawdragon 500 Leading Plaintiff Financial Lawyers 2019

    Chris has been selected for inclusion on Lawdragon’s 2019 list of 500 Leading Plaintiff Financial Lawyers. This guide, first published in 2007 by Lawdragon Inc., presents Lawdragon’s opinion of “the best of the U.S. plaintiff bar who specialize in representing individual investors and shareholders, as well as businesses and other organizations harmed by corporate misconduct or other failures.” Lawdragon’s selection methodology is based on a combination of objective criteria including research of top verdicts and settlements, peer recognition, and interviews with lawyers throughout the country. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

  • Award

    Lawdragon 500 Leading Plaintiff Consumer Lawyers 2019-2021

    Chris has been selected for inclusion on Lawdragon’s 2019-2020 list of 500 Leading Plaintiff Consumer Lawyers. This guide, first published in 2007 by Lawdragon Inc., presents Lawdragon’s opinion of “the best of the U.S. plaintiff bar who specialize in representing individuals who have suffered injuries from accidents, pharmaceuticals, civil rights abuse and other torts.” Lawdragon’s selection methodology is based on a combination of objective criteria including research of top verdicts and settlements, peer recognition, and interviews with lawyers throughout the country. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

  • Award

    The Trial Lawyer RoundTable: Top 50 Most Influential Trial Lawyers, 2016

    Chris was recognized by the Trial Lawyer RoundTable in 2016 as Top 50 Most Influential Trial Lawyers. The Trial Lawyer RoundTable selection methodology can be found here.

  • Award

    National Law Journal, Top 50 Litigation Trailblazers and Pioneers, 2014

     

    National Law Journal, Plaintiffs’ Lawyer Trailblazers, 2021

    Chris was recognized by The National Law Journal in 2014 as Top 50 Litigation Trailblazers and Pioneers. According to the editors of The National Law Journal, Chris has

    “Changed the practice of litigation through the use of innovative legal strategies.”

    Each year, The National Law Journal features several Trailblazer issues and accepts nominees from readers for who they believe made an impact in their respective practice areas. The publication’s editor reviews the nominees and selects 20 to 25 nominees for each practice area. A profile for each honoree is included in The National Law Journal’s Plaintiffs’ Lawyers Trailblazers.

  • Award

    New York Super Lawyers, 2006-2021

    New Jersey Super Lawyers, 2016-2021

    Chris was selected to the New York Super Lawyers list from 2006 through 2020, and the New Jersey Super Lawyers list from 2016 through 2020. The Super Lawyers list is issued by Thomson Reuters. The Super Lawyers selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

  • Award

    New Jersey Law Journal Top 20 Personal Injury Awards of the Year, 2007

    Chris was recognized by the New Jersey Law Journal on the list of Top 20 Personal Injury Awards of the Year, 2007. The New Jersey Law Journal is published by ALM Media Properties, LLC.

  • Award

    Cardozo Law Alumnus of the Year, 2009

  • Award

    Hunter College Alumni Hall of Fame, 2007

    Hunter College Distinguished Alumni Lawyer Award, 2013

  • Award

    Legal 500

    Chris was described by the editors of Legal 500 United States as:

    “A renowned trial lawyer.”

    “A determined trial lawyer.”

    “Highly regarded.”

    The selection methodology for the Legal 500 rankings can be found here.

  • Award

    National Trial Lawyers: Top 100 Trial Lawyers, 2016-2021

    Chris was recognized by the National Trial Lawyers on the list of Top 100 Trial Lawyers from 2016 through 2018. According to the editor of National Trial Lawyers, Chris is:

    “One of the nation’s most versatile, respected and accomplished attorneys in cases related to drug and toxic injury, as well as in the area of personal injury litigation.”

    “Mr. Seeger has served as lead attorney and in other significant leadership roles in many of the country’s most newsworthy and groundbreaking federal and state actions involving consumer fraud and negligence.”

    “Mr. Seeger approaches each case with compassion, knowing that each plaintiff, whether as an individual or as part of a large group, has suffered immensely and needs an effective partner to get through what is inevitably a difficult and emotional time. His success in the courtroom and at the settlement table have helped many injured people recover financial awards.”

    The National Trial Lawyers selection methodology can be found here.

Publications & Presentations

Member, leadership council, Bolch Judicial Institute, Duke Law

Adjunct professor, Trial Advocacy and Complex Litigation, Benjamin N. Cardozo School of Law

Presenter, “Global Settlements in Today’s Mass Tort Litigation,” Mass Tort Litigation Conference, Perrin Conferences, Thursday, June 24, 2021

Presenter, “Class-Action Challenges,” Class Action Case Law and Practices Review Bench-Bar Conference, James F. Humphreys Complex Litigation Center, George Washington University School of Law, November 13, 2020

Presenter, “Are MDL Judges Too Powerful?”, The Federalist Society, November 10, 2020

Adjunct professor, “Initial Stages and the JPML” & “Settlement,” Mass-Tort MDL Certificate Program, Bolch Judicial Institute, Duke Law, November 9, 2020

Presenter, “Opioid Litigation: What’s New, and What Does It Mean for Future Litigation?”, RAND Institute for Civil Justice, October 22, 2020

Presenter, “MDLs & Class Actions: A Discussion with Chris Seeger and Elizabeth Burch,” Center on Civil Justice, NYU School of Law, October 20, 2020

Presenter, “The Role of the Trial in Modern Complex Litigation,” Northwestern Pritzker School of Law, November 28, 2018

Presenter, “The ABCs of Settling Mass Torts,” ABA Current Issues in Pharmaceutical, Medical Device, and Biotech Litigation Regional CLE Program, November 9, 2018

Presenter, “Third Party Litigation Finance of Attorneys in Traditional and Complex Litigation,” George Washington University Law School, November 2, 2018

Presenter, “NFL Players’ Concussion Injury Litigation,” 2018 Transferee Judges’ Conference, October 30, 2018

Presenter, “The NFL Concussion Litigation: The Impact of Traumatic Brain Injury on America’s Most Popular Sport,” Fordham Law School, October 17, 2018

Presenter, “Theory of Aggregation: Class Actions, MDLs, Bankruptcies, and More,” NYU School of Law, October 12, 2018

Presenter, “FBA: Perspectives on Class Action and Multi District Litigation,” 2018 FBA Annual Meeting & Convention, September 13, 2018

Presenter, “Impact of Critical Transferee Judge Decisions Not Subject to Review or Appeal,” Duke University School of Law, April 26, 2018

Presenter, “How Does it End – Settlement, Trial, or Remand,” Federal Judicial Center, March 15, 2018

Presenter, Bolch Judicial Institute, Duke University School of Law, March 13, 2018

Presenter, “NFL Concussion Case Study,” Columbia Law School, March 2, 2018

Presenter, “Current Issues in the Trial of Complex Matters,” Northwestern Pritzker School of Law, November 30, 2017

Presenter, “Mass Tort Trends – 1,000 Claimants to 100 Million,” Mass Tort Global Settlement Architecture Conference, October 27, 2017

Presenter, “Trying Cases and Settlement,” Federalist Society, October 19, 2017

Presenter, Emory Law School Bridge Program, September 14, 2017

Presenter, “The Aggregation of Claims: Pros and Cons,” RAND Institute for Civil Justice, May 19, 2017

Presenter, “Limits on Judicial Participation in and Approval of Non-Class Settlements,” George Washington University Law School, April 27, 2017

Presenter, “Case Management Techniques: What Helps, What Backfires, and How to Get to Efficient Resolution,” Emory Law Institute for Complex Litigation and Mass Claims, December 14, 2016

Presenter, “There’s No Place like Home: The Pros and Cons of Lexecon Waivers and Bellwether Trials in the Modern MDL,” American Bar Association Continuing Legal Education Workshop, November 4, 2016

Presenter, “Bellwether Trials? Purpose, Including Whether to Eliminate Them Altogether, Selection, and Early Dismissal,” Duke Law Center for Judicial Studies, October 28, 2016

Presenter, “NFL: The challenges and rewards of serving as lead counsel in one of the most highly publicized class actions in history,” Oregon Law Institute of Lewis & Clark Law School, February 16, 2016

Presenter, “Trials & Error: The NFL Concussion Settlement,” NYU School of Law, February 2, 2016

Presenter, “Volkswagen Diesel Emissions Fraud: Arguments for Potential Transfer Venues,” American Association for Justice, December 2, 2015

Presenter, “Common Benefit Funds,” Duke Law Center for Judicial Studies, November 9, 2015

Presenter, “Common Benefit Fund/Attorney Fees,” Duke Law Center for Judicial Studies, May 2, 2013

Managing Editor, Cardozo Law Review, 1990

FREE CASE EVALUATION

Since its establishment in 1999, Seeger Weiss has led some of the most complex and high-profile litigations in the U.S.